Bupa has agreed to acquire Partnered Health Group, a deal that would add 68 primary care clinics, three urgent care clinics, and five corporate health and wellbeing brands to the insurer’s provider network. The transaction requires clearance from the Australian Competition and Consumer Commission (ACCC) and the Foreign Investment Review Board (FIRB) before it can proceed. The deal marks a further step in Bupa’s expansion from insurance into direct care delivery. The company held a 25.6% share of the Australian private health insurance market as of the December quarter – a position built over three consecutive years of market share growth – and has been adding clinical infrastructure alongside that. In FY2025 alone, it opened 27 medical centres and 10 mental health clinics, bringing its total to 32 medical centres and 13 Mindplace clinics. The Partnered Health acquisition, if cleared, would add 68 primary care clinics to that count.
Partnered Health’s primary care clinics cover general practice, skin cancer, allied health, and mental health services. The three urgent care clinics represent a service type Bupa does not currently offer. The corporate health component – delivered through Jobfit, Baseline Onsite, New View Psychology, NewPsych Psychology, and Australian EAP – would extend Bupa’s reach into workplace and government health contracts, an area Bupa APAC CEO Nick Stone said the company has been building independently.
Stone said the case for the acquisition rested on both the clinical network and the corporate health platform. “As a diversified health care provider, we’re focused on what we can do to better meet the health and wellbeing needs of Australians, as well as help support the careers of the GPs and clinicians that deliver that care,” Stone said. He added that early access to care was central to the company’s rationale for expanding its provider footprint. “Our ambition is to improve patient care through prevention and more personalised pathways, while preserving consumer choice and clinical independence. We know when people get care earlier, health outcomes improve and costs fall. That’s good for patients and Australia’s healthcare system,” he said.
Partnered Health managing director and CEO Dr. Malcolm Parmenter said the deal would allow the business to extend its services while continuing its existing operations. “This is an exciting opportunity for Partnered Health to continue to deliver high quality healthcare outcomes for our patients and customers. The combination with Bupa will enable us to continue to support our clinicians and our people while growing our clinic footprint and expanding our service offering,” Parmenter said.
The question of clinical independence is likely to receive scrutiny during the ACCC review process, given the scale of Bupa’s vertical integration across insurance and care delivery. Both executives addressed the issue directly. Stone stated that Bupa’s clinics are not restricted to its own policyholders and that doctors operate independently of the insurer’s commercial interests. “Our Bupa clinics are open to everyone, not just Bupa members. We continue to support full clinical autonomy for doctors and respect the critical role they play in helping to achieve better health outcomes for patients,” he said. Parmenter said Bupa had made an explicit commitment to preserve the independence that Partnered Health clinicians currently hold. “Importantly for all of us, Bupa is committed to that same clinical autonomy that our clinicians have always enjoyed at Partnered Health,” he said.
Bupa APAC’s FY2025 results provide context for where the company’s insurance and care delivery businesses currently stand. Revenue rose 6% to $12.9 billion, driven by a 400,000-customer increase across its Australian, New Zealand, and Hong Kong operations, which collectively served more than 11 million people by year’s end. Underlying profit reached $947 million, up 10% on the prior year. In Australia, hospital and extras benefit payments totalled $6.65 billion, up from $6.28 billion the prior year. The company’s Blua telehealth platform, used by 367,000 customers in FY2025, resolved 69% of consultations at the first appointment. Those figures indicate that Bupa’s provider expansion has been running alongside membership and revenue growth in its insurance book, rather than as a response to declining performance in either. The Partnered Health acquisition, if it clears regulatory review, would be the next step in that pattern – and the one that will draw the most attention from competitors and regulators tracking Bupa’s growing presence across both sides of the private health market.
